CMR-derived Quantitative Perfusion for Prediction of FFR
ConditionChronic Coronary Syndrome
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorKerckhoff Klinik
About this trial
Patients will undergo quantitative perfusion assessment in cardiovascular magnetic resonance imaging (dual bolus or dual sequence approach) as well as invasive coronary angiography for assessment of fractional flow reserve (FFR) including assessment of coronary flow reserve (CFR) and microcirculatory resistance (IMR).
Eligibility criteria
Qualifiers
clinical indication for vasodilatator CMR or invasive coronar angiography
capability to give informed consent
Disqualifiers
general: non-compliance, <18 years of age, pregnancy
contraindications for CMR (non-CMR compatible device, chronic kidney disease (eGFR <30ml/min), allergies (medications)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
200 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov